Immunohistochemical Expression of Galectin-8, VEGF-C and VEGFR-3 in Epithelial Ovarian Carcinoma: Associations with Clinicopathological Features
Current Issues in Molecular Biology · 18.11.2026 · 48 (11) · 1243
DOI: 10.3390/cimb48111243 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 18.11.2026. Verfasst von Elena-Roxana Avădănei und 8 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Ovarian carcinoma (OC) is one of the most lethal gynecological malignancies. Galectin-8 (Gal-8) and the VEGF-C/VEGFR-3 lymphangiogenic axis have each been implicated in OC progression, but they have not been examined together in a histotype-resolved series. In this retrospective, cross-sectional, single-center study of 84 epithelial OC cases, Gal-8, VEGF-C and VEGFR-3 immunoexpression was related to histological type, Type I/Type II classification, pT-based stage and residual disease, with correction for multiple testing (q). Gal-8 was nuclear in all 34 high-grade serous carcinomas (HGSCs) and all 42 Type II tumors, whereas cytoplasmic and mixed patterns occurred almost only in low-grade and Type I tumors. A high Gal-8 score was associated with HGSC and Type II histology, poor differentiation, advanced stage and residual disease (odds ratios, all q ≤ 0.004). VEGF-C and VEGFR-3 were expressed in 67.86% and 73.81% of cases, more often in high-grade and advanced tumors, and in all stage III tumors. No statistically significant association was detected between Gal-8 and VEGF-C or VEGFR-3, but the cohort was too small for this comparison to be conclusive. Gal-8, VEGF-C and VEGFR-3 are each associated with aggressive features of OC. This study cannot show whether this reflects a shared aggressive phenotype or a functional interaction between the markers. Without outcome data or multivariable analysis, these findings are descriptive, not prognostic, and hypothesis-generating.
Zitieren
APA
Avădănei, E., Căruntu, I., Păvăleanu, I., Pruteanu, A. I., Giușcă, S., Rusu, A., Bordeianu, G., Bîcă, O., & Lozneanu, L. (2026). Immunohistochemical Expression of Galectin-8, VEGF-C and VEGFR-3 in Epithelial Ovarian Carcinoma: Associations with Clinicopathological Features. Current Issues in Molecular Biology, 48(11), 1243. https://doi.org/10.3390/cimb48111243
Vancouver
Avădănei E, Căruntu I, Păvăleanu I, Pruteanu AI, Giușcă S, Rusu A, et al. Immunohistochemical Expression of Galectin-8, VEGF-C and VEGFR-3 in Epithelial Ovarian Carcinoma: Associations with Clinicopathological Features. Current Issues in Molecular Biology. 2026;48(11):1243. doi:10.3390/cimb48111243
BibTeX
@article{Avdnei2026,
author = {Avădănei, Elena-Roxana and Căruntu, Irina-Draga and Păvăleanu, Ioana and Pruteanu, Andreea Ioana and Giușcă, Simona-Eliza and Rusu, Andreea and Bordeianu, Gabriela and Bîcă, Ovidiu and Lozneanu, Ludmila},
title = {Immunohistochemical Expression of Galectin-8, VEGF-C and VEGFR-3 in Epithelial Ovarian Carcinoma: Associations with Clinicopathological Features},
journal = {Current Issues in Molecular Biology},
year = {2026},
volume = {48},
number = {11},
pages = {1243},
doi = {10.3390/cimb48111243}
}
EUVIMED